ABFM //Heart //Disease //KSA //Exam //Questions
//With //Correct //Answers
Correlation //between //heart //disease //and //hypothyroidism? //- //correct //answer(s) //✔✔ //Clinical
//hypothyroidism //has //long //been //associated //with //cardiac //dysfunction. //It //has //also //been
//shown //that //subclinical //hypothyroidism //(TSH //>4 //µU/mL //with //normal //or //borderline //low
//thyroid //hormone //levels) //can //cause //left //ventricular //systolic //and //diastolic //dysfunction,
//which //improves //with //thyroid //replacement //therapy. //Patients //with //overt //or //subclinical
//hypothyroidism //should //be //treated //with //levothyroxine //to //improve //their //cardiovascular
//function //and //decrease //the //potential //risk //of //heart //failure. //Thyroxine //in //excess //can
//exacerbate //coronary //artery //disease, //and //should //be //started //at //low //doses //and //increased
//slowly //in //patients //with //possible //underlying //coronary //artery //disease. //Results //of //meta-
analyses //indicate //that //therapy //will //lower, //not //raise, //serum //LDL-cholesterol //levels.
Option //for //pts //w/ //severe //HF //awaiting //heart //transplant? //- //correct //answer(s) //✔✔
//Mechanical //circulatory //support //(MCS) //with //a //ventricular //assist //device //has //emerged //as //a
//viable //therapeutic //option //for //patients //with //advanced //stage //D //heart //failure //with
//reduced //ejection //fraction //refractory //to //guideline-directed //medical //therapy //and //cardiac
//device //intervention. //These //devices //may //be //either //intracorporeal //or //extracorporeal, //and
//may //be //designed //to //assist //the //left //ventricle, //right //ventricle, //or //both. //Bridge //therapy
//refers //to //the //use //of //left //ventricular //assist //devices //to //help //a //patient //survive //until //a
//donor //heart //becomes //available //for //transplantation. //Several //devices //are //available, //some
//of //which //are //implantable //and //allow //patients //to //be //discharged //to //their //homes. //These
//devices //can //increase //patient //activity //levels //and //quality //of //life. //Complications //can //occur,
//including //stroke, //infection, //and //death, //but //these //devices //can //be //lifesaving //in //patients
//with //refractory //heart //failure.
In //a //meta-analysis //of //symptoms //useful //in //diagnosing //acute //coronary //syndrome //in //a
//low-risk //setting, //________ //was //found //to //be //the //strongest //predictor //of //myocardial
//infarction //- //correct //answer(s) //✔✔ //Diaphoresis
